- Home
- LICN vs KZR Comparison
LICN vs KZR Comparison
Compare LICN & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LICN | KZR |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.5M | 45.8M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LICN | KZR |
|---|---|---|
| Price | $3.11 | $6.26 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 63.9K | 30.5K |
| Earning Date | 12-19-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,641,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.57 | $3.53 |
| 52 Week High | $40.00 | $6.93 |
Technical Indicators
Market Signals| Indicator | LICN | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 55.96 |
| Support Level | $2.80 | $6.22 |
| Resistance Level | $3.11 | $6.35 |
| Average True Range (ATR) | 0.23 | 0.10 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 12.77 | 59.09 |
Price Performance
Historical ComparisonAbout LICN Lichen China Limited
Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.